Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 136 AL 150

Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis

Wang M, Tang G, Zhou C, Guo H, Hu Z, Hu Q, Li G.

Chem Biol Interact. 2023 Apr 25;375:110387. doi: 10.1016/j.cbi.2023.110387. Epub 2023 Feb 8.

The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease

Sahlgren Bendtsen KM, Hall VJ.

Cells. 2023 Jan 27;12(3):420. doi: 10.3390/cells12030420.

The Pursuit of the "Inside" of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer's Disease?

Takasugi N, Komai M, Kaneshiro N, Ikeda A, Kamikubo Y, Uehara T.

Cells. 2023 Jan 31;12(3):454. doi: 10.3390/cells12030454.

Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer's Disease Progression

Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, Jurcau A, Jurcau MC, Pascalau N, Marcu F.

Int J Mol Sci. 2023 Jan 18;24(3):1869. doi: 10.3390/ijms24031869.

Natural Inhibitors of Cholinesterases: Chemistry, Structure-Activity and Methods of Their Analysis

Smyrska-Wieleba N, Mroczek T.

Int J Mol Sci. 2023 Feb 1;24(3):2722. doi: 10.3390/ijms24032722.

Lipoprotein Metabolism, Protein Aggregation, and Alzheimer's Disease: A Literature Review

Grao-Cruces E, Claro-Cala CM, Montserrat-de la Paz S, Nobrega C.

Int J Mol Sci. 2023 Feb 2;24(3):2944. doi: 10.3390/ijms24032944.

A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease

Peitzika SC, Pontiki E.

Molecules. 2023 Jan 21;28(3):1084. doi: 10.3390/molecules28031084.

Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease

Deng M, Yan W, Gu Z, Li Y, Chen L, He B.

Molecules. 2023 Feb 3;28(3):1486. doi: 10.3390/molecules28031486.

Could Alzheimer's disease be a maladaptation of an evolutionary survival pathway mediated by intracerebral fructose and uric acid metabolism?

Johnson RJ, Tolan DR, Bredesen D, Nagel M, Sánchez-Lozada LG, Fini M, Burtis S, Lanaspa MA, Perlmutter D.

Am J Clin Nutr. 2023 Mar;117(3):455-466. doi: 10.1016/j.ajcnut.2023.01.002. Epub 2023 Jan 11.

Aducanumab for the treatment of Alzheimer's disease: a systematic review

Rahman A, Hossen MA, Chowdhury MFI, Bari S, Tamanna N, Sultana SS, Haque SN, Al Masud A, Saif-Ur-Rahman KM.

Psychogeriatrics. 2023 May;23(3):512-522. doi: 10.1111/psyg.12944. Epub 2023 Feb 12.

Stress and the risk of Alzheimer dementia: Can deconstructed engrams be rebuilt?

Jeanneteau F.

J Neuroendocrinol. 2023 Sep;35(9):e13235. doi: 10.1111/jne.13235. Epub 2023 Feb 12.

A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia

Cooper J, Pastorello Y, Slevin M.

Front Immunol. 2023 Jan 27;14:1087571. doi: 10.3389/fimmu.2023.1087571. eCollection 2023.

Elucidating the promising role of traditional Chinese medicine in neuroprotection against oxidative stress encompassing Alzheimer's disease

Arora A, Behl T, Sehgal A, Singh S, Sharma N, Abdellatif AAH, Dailah HG, Bhatia S, Al-Harrasi A, Aleya L, Bungau S.

Environ Sci Pollut Res Int. 2023 Mar;30(14):39546-39557. doi: 10.1007/s11356-023-25800-4. Epub 2023 Feb 15.

Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring

Roughley M, Mena C, Howard R, Reeves S, Bertrand J.

Br J Clin Pharmacol. 2023 Jul;89(7):2316-2321. doi: 10.1111/bcp.15692. Epub 2023 Feb 28.

Cancer and Alzheimer's Inverse Correlation: an Immunogenetic Analysis

Bhardwaj A, Liyanage SI, Weaver DF.

Mol Neurobiol. 2023 Jun;60(6):3086-3099. doi: 10.1007/s12035-023-03260-8. Epub 2023 Feb 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias